Home Pharmaceutics Beyond Botox: AbbVie’s push for broader gains in neurotoxin R&D

Beyond Botox: AbbVie’s push for broader gains in neurotoxin R&D

by Newsroom


This audio is auto-generated. Please let us know if you have feedback.

Botox has been synonymous with aesthetics for decades, even achieving the elusive and sometimes frustrating status of being shorthand for an entire category of products.

But Botox’s first approvals in 1989 weren’t aimed at reducing wrinkles. Instead, they targeted two rare eye muscle disorders, showcasing the…



Source link

You may also like

About Us

Pharma Newswire™ aggregates, publishes and distributes news in the Pharmaceutical Industry. In association with EmailWire, Pharma Newswire™ provides press release distribution services in the pharmaceutical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. To send a press release, contact us through the following messaging apps:

Pharma Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC